Alseres Pharmaceuticals Inc (ALSE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2009 | 03-2009 | 12-2008 | 09-2008 | 06-2008 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 38 | 502 | 74 | 1,336 | 5,399 |
| Other current assets | 69 | 69 | 80 | 0 | 0 |
| TOTAL | $261 | $835 | $317 | $1,750 | $6,576 |
| Non-Current Assets | |||||
| PPE Net | 139 | 159 | 179 | 199 | 76 |
| Other Non-Current Assets | 310 | 314 | 349 | 369 | 299 |
| TOTAL | $449 | $473 | $528 | $568 | $375 |
| Total Assets | $709 | $1,308 | $845 | $2,318 | $6,951 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 4,162 | 4,818 | 4,896 | 4,150 | 4,630 |
| Accrued Expenses | 42 | 42 | 45 | 49 | 52 |
| TOTAL | $5,230 | $5,860 | $4,941 | $4,199 | $4,682 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 40,121 | 37,496 | 35,917 | 35,326 | 34,850 |
| TOTAL | $40,121 | $37,496 | $35,917 | $35,326 | $34,850 |
| Total Liabilities | $45,351 | $43,357 | $40,859 | $39,525 | $39,532 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 5 | 5 | 5 | 4 | 4 |
| Common Shares | 231 | 231 | 214 | 209 | 208 |
| Retained earnings | -190,864 | -188,248 | -183,899 | -179,604 | -174,493 |
| TOTAL | $-44,642 | $-42,049 | $-40,013 | $-37,207 | $-32,581 |
| Total Liabilities And Equity | $709 | $1,308 | $845 | $2,318 | $6,951 |